William H. Grieb

Array ( [id] => 7313019 [patent_doc_number] => 20040143855 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'Ion channels as targets for sleep-related drugs' [patent_app_type] => new [patent_app_number] => 10/745210 [patent_app_country] => US [patent_app_date] => 2003-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 16413 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20040143855.pdf [firstpage_image] =>[orig_patent_app_number] => 10745210 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 369608 [patent_doc_number] => 07476381 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-01-13 [patent_title] => 'Methods of reducing serum alanine transferase levels in a subject with hepatitis' [patent_app_type] => utility [patent_app_number] => 10/540234 [patent_app_country] => US [patent_app_date] => 2003-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6943 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/476/07476381.pdf [firstpage_image] =>[orig_patent_app_number] => 10540234 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7372386 [patent_doc_number] => 20040219204 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => 'Method of treating angiogenic tissue growth' [patent_app_type] => new [patent_app_number] => 10/742074 [patent_app_country] => US [patent_app_date] => 2003-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5186 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20040219204.pdf [firstpage_image] =>[orig_patent_app_number] => 10742074 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 806794 [patent_doc_number] => 07420029 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-02 [patent_title] => 'Tissue-specific transporter inhibitor' [patent_app_type] => utility [patent_app_number] => 10/742335 [patent_app_country] => US [patent_app_date] => 2003-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10622 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/420/07420029.pdf [firstpage_image] =>[orig_patent_app_number] => 10742335 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5694169 [patent_doc_number] => 20060154316 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-13 [patent_title] => 'Elisa method for the detection of guanylate binding protein 1 (gbp-1)' [patent_app_type] => utility [patent_app_number] => 10/537607 [patent_app_country] => US [patent_app_date] => 2003-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7287 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0154/20060154316.pdf [firstpage_image] =>[orig_patent_app_number] => 10537607 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7276281 [patent_doc_number] => 20040235732 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Method for modulating angiogenesis using prokineticin receptor antagonists' [patent_app_type] => new [patent_app_number] => 10/713567 [patent_app_country] => US [patent_app_date] => 2003-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12320 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20040235732.pdf [firstpage_image] =>[orig_patent_app_number] => 10713567 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7343650 [patent_doc_number] => 20040191853 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-30 [patent_title] => 'Cellular physiology workstations for automated data acquisition and perfusion control' [patent_app_type] => new [patent_app_number] => 10/705755 [patent_app_country] => US [patent_app_date] => 2003-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 13302 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20040191853.pdf [firstpage_image] =>[orig_patent_app_number] => 10705755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5828908 [patent_doc_number] => 20060063711 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-23 [patent_title] => 'Use of sglt homolog' [patent_app_type] => utility [patent_app_number] => 10/533066 [patent_app_country] => US [patent_app_date] => 2003-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 32743 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20060063711.pdf [firstpage_image] =>[orig_patent_app_number] => 10533066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5739125 [patent_doc_number] => 20060009516 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-12 [patent_title] => 'Use of ingap for reversing diabetes' [patent_app_type] => utility [patent_app_number] => 10/532426 [patent_app_country] => US [patent_app_date] => 2003-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3938 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20060009516.pdf [firstpage_image] =>[orig_patent_app_number] => 10532426 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5866149 [patent_doc_number] => 20060100280 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-11 [patent_title] => 'Cell growth regulator' [patent_app_type] => utility [patent_app_number] => 10/531177 [patent_app_country] => US [patent_app_date] => 2003-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6899 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20060100280.pdf [firstpage_image] =>[orig_patent_app_number] => 10531177 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7336744 [patent_doc_number] => 20040132655 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'New combination' [patent_app_type] => new [patent_app_number] => 10/677931 [patent_app_country] => US [patent_app_date] => 2003-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1025 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20040132655.pdf [firstpage_image] =>[orig_patent_app_number] => 10677931 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7203187 [patent_doc_number] => 20050042719 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Adipocyte complement related protein homolog zacrp5' [patent_app_type] => utility [patent_app_number] => 10/676790 [patent_app_country] => US [patent_app_date] => 2003-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 27970 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20050042719.pdf [firstpage_image] =>[orig_patent_app_number] => 10676790 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7288649 [patent_doc_number] => 20040109866 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Method and composition' [patent_app_type] => new [patent_app_number] => 10/471816 [patent_app_country] => US [patent_app_date] => 2003-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4881 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0109/20040109866.pdf [firstpage_image] =>[orig_patent_app_number] => 10471816 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7281252 [patent_doc_number] => 20040063629 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-01 [patent_title] => 'Treatment of damaged connective tissue' [patent_app_type] => new [patent_app_number] => 10/275175 [patent_app_country] => US [patent_app_date] => 2003-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7479 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20040063629.pdf [firstpage_image] =>[orig_patent_app_number] => 10275175 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7206513 [patent_doc_number] => 20040087505 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'Synthetic heparin-binding factor analogs' [patent_app_type] => new [patent_app_number] => 10/644703 [patent_app_country] => US [patent_app_date] => 2003-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16477 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20040087505.pdf [firstpage_image] =>[orig_patent_app_number] => 10644703 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7397361 [patent_doc_number] => 20040038896 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-26 [patent_title] => 'Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof' [patent_app_type] => new [patent_app_number] => 10/640326 [patent_app_country] => US [patent_app_date] => 2003-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 20940 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20040038896.pdf [firstpage_image] =>[orig_patent_app_number] => 10640326 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7201770 [patent_doc_number] => 20040086863 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'Ph interacting protein' [patent_app_type] => new [patent_app_number] => 10/275762 [patent_app_country] => US [patent_app_date] => 2003-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 32222 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20040086863.pdf [firstpage_image] =>[orig_patent_app_number] => 10275762 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7314194 [patent_doc_number] => 20040033954 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-19 [patent_title] => 'Therapeutic method for combined use of modified CNTF and thiadolidinedione' [patent_app_type] => new [patent_app_number] => 10/639107 [patent_app_country] => US [patent_app_date] => 2003-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3436 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20040033954.pdf [firstpage_image] =>[orig_patent_app_number] => 10639107 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7220163 [patent_doc_number] => 20040072219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Modified leptin with reduced immunogenicity' [patent_app_type] => new [patent_app_number] => 10/467114 [patent_app_country] => US [patent_app_date] => 2003-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11460 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20040072219.pdf [firstpage_image] =>[orig_patent_app_number] => 10467114 [rel_patent_id] =>[rel_patent_doc_number] =>)